Neurxstem Inc

10/13/2025

Neurxstem - Business Plan for Clinical Brain Disease Market Milestone Podcast
https://lnkd.in/ePYRPhr5

Contact us if you would like to join us as investors, joint ventures or supporters and leave a legacy in medicine too!
neurxstem.com

Neurxstem Inc. a Precision Brain Medicine Company Tackles Alzheimer’s, Parkinson’s, Autism, Addiction, and Aging with Groundbreaking Brain Health Technology

“A New Era for Brain Health Has Begun.”

Breakthroughs Announced by Neurxstem
• Alzheimer’s Disease - Genetic susceptibility markers, environmental toxins and nutritional deficiencies have been identified as major contributors. Preventive nutrition and novel therapies have shown early promise, as do targeted drugs, some repurposed.
• Parkinson’s Disease - Genetic susceptibility markers, environmental toxins and nutritional deficiencies have been identified as major contributors. Novel therapeutic targets have been identified.
• Autism - Early research links exposure to toxins (like lead and pesticides) and nutrient imbalances to increased autism risk. Neurxstem has identified potential genetic susceptibility markers.
• Opioid Use Disorder (OUD) - Neurxstem has developed the first lab-grown brain model that replicates how opioids like fentanyl affect reward and pain systems, helping pinpoint those most at risk.
Potential drug targets in specific neural networks have been identified for therapeutic intervention
• Ageing - A new “Progeria brain model” developed by Neurxstem mirrors the neural gene networks and hallmarks of human brain ageing, opening doors to better understanding and drugs and diets which have the potential of to slow cognitive decline.

10/13/2025

Neurxstem PODCAST #3 - Aging, Wellness, Longevity and Health Span Portfolio
https://lnkd.in/excVAD-Q

Contact us if you would like to join us as investors, joint ventures or supporters and leave a legacy too!
neurxstem.com

Neurxstem Inc. a Precision Brain Medicine Company - “A New Era for Brain Health Has Begun.”

10/13/2025

Neurxstem PODCAST #4 - AI healthcare and Predictive Analytics for Prodromal Brain Health Applications
https://lnkd.in/e-zCK2SR

Contact us if you would like to join us as investors, joint ventures or supporters and leave a legacy too!
neurxstem.com
Neurxstem Inc. a Precision Brain Medicine Company - “A New Era for Brain Health Has Begun.”

10/13/2025

Neurxstem PODCAST #2 - Medical Portfolio of Early Diagnostics and Therapeutic Drugs
https://lnkd.in/e9rtgqKW

Contact us if you would like to join us as investors, joint ventures or supporters and leave a legacy too!
neurxstem.com

Neurxstem Inc. a Precision Brain Medicine Company - “A New Era for Brain Health Has Begun.”

https://www.youtube.com/watch?v=ey2RR-z0UGM

11/14/2021

Neurxstem Inc has been awarded a Phase I SBIR contract by AFWERX, the group that enables the U.S. Air Force and U.S. Space Force to adopt cutting-edge commercially available technology into their practices.

Neurxstem was awarded the contract to develop human stem cell brain models of Post Traumatic Stress Disorder among US military personnel and veterans for diagnostic and therapeutic purposes. The medical technology when developed will also help civilians suffering from PTSD.

“Many mind-blowing ideas are being birthed in U.S. startup companies. In order to capture these ideas, the DoD must do business at the speed of innovation; inspiring and accelerating startup creativity toward national security challenges,” noted the AFWERX team of their SBIR program in partnership with Air Force Research Lab (AFRL).

AFVentures, the commercial investment arm of the Air Force, creates simple pathways for commercial innovators and private capital investment to help the Department of the Air Force solve problems.

08/31/2020

Neurxstem Opens Facility in Heath’s Port Authority, Begins Opioid and COVID-19 Countermeasure Research

Neurxstem, a predictive and precision genomic medicine company that delivers the world’s first and most advanced synthetic human ’brain-diseases-in-a-dish’, has opened a facility at the Heath-Newark-Licking County Port Authority.

08/27/2020

Neurxstem is a winner of the International Brain Race organized by the Center for Advancing Innovation.

BETHESDA, Md. (PRWEB) April 23, 2020 -- The Center for Advancing Innovation (CAI) announces winners of the Brain Race, an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors. The Brain Race launched 15 start-up companies, which are advancing promising thera...